301277SZSE

Announcement of Resolutions from the Tenth Meeting of the Sixth Board of Directors

Newland Pharmaceutical Co., Ltd.·February 26, 2026

✨ AI Summary

The announcement details the resolutions passed during the Tenth Meeting of the Sixth Board of Directors of Xintiandi Pharmaceutical Co., Ltd. on February 26, 2026. The board approved the use of part of the idle raised funds and self-owned funds for cash management, ensuring no impact on project construction or company operations. The decision received unanimous support from the attending directors.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· azure_openai

Securities Code: 301277
Securities Abbreviation: Xintiandi
Announcement Number: 2026-002

Announcement of Resolutions from the Tenth Meeting of the Sixth Board of Directors

Xintiandi Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the content of this announcement is true, accurate, and complete, with no false records, misleading statements, or significant omissions.

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.